Photo from wikipedia
Background: Therapy with sacubitril/valsartan improves outcome in those with heart failure with reduced ejection fraction (HFrEF). Questions remain regarding effect of sacubitril/valsartan on left ventricular (LV) remodeling as well as… Click to show full abstract
Background: Therapy with sacubitril/valsartan improves outcome in those with heart failure with reduced ejection fraction (HFrEF). Questions remain regarding effect of sacubitril/valsartan on left ventricular (LV) remodeling as well as its effects on circulating biomarkers (including B-type
Keywords:
ventricular remodeling;
therapy;
study;
heart failure
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!